Prostate cancer treatment in Portugal: a nationwide analysis
Abstract Different treatment options exist for localized prostate cancer. Treatments performed in high-volume hospitals are associated with better results. Our objective was to describe time trends in prostate cancer treatments in Portugal and case volume per hospital. We used the national database...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-46591-1 |
_version_ | 1827764478877368320 |
---|---|
author | Francisco Botelho Rui Lopes Francisco Pina Carlos Silva Luís Pacheco-Figueiredo Nuno Lunet |
author_facet | Francisco Botelho Rui Lopes Francisco Pina Carlos Silva Luís Pacheco-Figueiredo Nuno Lunet |
author_sort | Francisco Botelho |
collection | DOAJ |
description | Abstract Different treatment options exist for localized prostate cancer. Treatments performed in high-volume hospitals are associated with better results. Our objective was to describe time trends in prostate cancer treatments in Portugal and case volume per hospital. We used the national database of diagnosis-related group of the Portuguese Central Administration of the Health System to describe the number of radical prostatectomy (RP), brachytherapy (BT) and external radiotherapy (eRT) treatments performed in all National Health System hospitals. There was a rapid increase in the annual number of RP until 2006 and then a deceleration; BT treatments augmented significantly until 2011. The utilization of eRT also increased, surpassing RP after 2010. From the 46 hospitals performing RP, only eight had a case-volume > 50 treatments/year, and from the nine hospitals performing BT, only four accomplished > 15 treatments/year. In the 11 hospitals with eRT, nine performed > 50/year. Regarding RP, there was negative correlation between the hospital volume and length of stay (r = − 0.303; p = 0.041). In the Portuguese National Health Service there was a steep increase in the number of prostate cancer treatments, and there is an ample margin for concentration of RP and BT treatments, for improvement of the hospitals case volume. |
first_indexed | 2024-03-11T11:05:02Z |
format | Article |
id | doaj.art-15cdd9bbe0c64138adf2346ed03376d2 |
institution | Directory Open Access Journal |
issn | 2045-2322 |
language | English |
last_indexed | 2024-03-11T11:05:02Z |
publishDate | 2023-11-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj.art-15cdd9bbe0c64138adf2346ed03376d22023-11-12T12:14:12ZengNature PortfolioScientific Reports2045-23222023-11-011311710.1038/s41598-023-46591-1Prostate cancer treatment in Portugal: a nationwide analysisFrancisco Botelho0Rui Lopes1Francisco Pina2Carlos Silva3Luís Pacheco-Figueiredo4Nuno Lunet5Serviço de Urologia do Centro Hospitalar Universitário S. JoãoEscola de Medicina, Universidade do MinhoServiço de Urologia do Centro Hospitalar Universitário S. JoãoServiço de Urologia do Centro Hospitalar Universitário S. JoãoServiço de Urologia do Centro Hospitalar Universitário S. JoãoDepartamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina, Universidade do PortoAbstract Different treatment options exist for localized prostate cancer. Treatments performed in high-volume hospitals are associated with better results. Our objective was to describe time trends in prostate cancer treatments in Portugal and case volume per hospital. We used the national database of diagnosis-related group of the Portuguese Central Administration of the Health System to describe the number of radical prostatectomy (RP), brachytherapy (BT) and external radiotherapy (eRT) treatments performed in all National Health System hospitals. There was a rapid increase in the annual number of RP until 2006 and then a deceleration; BT treatments augmented significantly until 2011. The utilization of eRT also increased, surpassing RP after 2010. From the 46 hospitals performing RP, only eight had a case-volume > 50 treatments/year, and from the nine hospitals performing BT, only four accomplished > 15 treatments/year. In the 11 hospitals with eRT, nine performed > 50/year. Regarding RP, there was negative correlation between the hospital volume and length of stay (r = − 0.303; p = 0.041). In the Portuguese National Health Service there was a steep increase in the number of prostate cancer treatments, and there is an ample margin for concentration of RP and BT treatments, for improvement of the hospitals case volume.https://doi.org/10.1038/s41598-023-46591-1 |
spellingShingle | Francisco Botelho Rui Lopes Francisco Pina Carlos Silva Luís Pacheco-Figueiredo Nuno Lunet Prostate cancer treatment in Portugal: a nationwide analysis Scientific Reports |
title | Prostate cancer treatment in Portugal: a nationwide analysis |
title_full | Prostate cancer treatment in Portugal: a nationwide analysis |
title_fullStr | Prostate cancer treatment in Portugal: a nationwide analysis |
title_full_unstemmed | Prostate cancer treatment in Portugal: a nationwide analysis |
title_short | Prostate cancer treatment in Portugal: a nationwide analysis |
title_sort | prostate cancer treatment in portugal a nationwide analysis |
url | https://doi.org/10.1038/s41598-023-46591-1 |
work_keys_str_mv | AT franciscobotelho prostatecancertreatmentinportugalanationwideanalysis AT ruilopes prostatecancertreatmentinportugalanationwideanalysis AT franciscopina prostatecancertreatmentinportugalanationwideanalysis AT carlossilva prostatecancertreatmentinportugalanationwideanalysis AT luispachecofigueiredo prostatecancertreatmentinportugalanationwideanalysis AT nunolunet prostatecancertreatmentinportugalanationwideanalysis |